Cargando…

The Dutch Parelsnoer Institute - Neurodegenerative diseases; methods, design and baseline results

BACKGROUND: The Parelsnoer Institute is a collaboration between 8 Dutch University Medical Centers in which clinical data and biomaterials from patients suffering from chronic diseases (so called “Pearls”) are collected according to harmonized protocols. The Pearl Neurodegenerative Diseases focuses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aalten, Pauline, Ramakers, Inez HGB, Biessels, Geert Jan, de Deyn, Peter Paul, Koek, Huiberdina L, OldeRikkert, Marcel GM, Oleksik, Ania M, Richard, Edo, Smits, Lieke L, van Swieten, John C, Teune, Laura K, van der Lugt, Aad, Barkhof, Frederik, Teunissen, Charlotte E, Rozendaal, Nico, Verhey, Frans RJ, van der Flier, Wiesje M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301568/ https://www.ncbi.nlm.nih.gov/pubmed/25551191 http://dx.doi.org/10.1186/s12883-014-0254-4

Ejemplares similares

Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer’s Disease
por: Geijselaers, Stefan L.C., et al.
Publicado: (2017)

Trajectories and Determinants of Quality of Life in Dementia with Lewy Bodies and Alzheimer’s Disease
por: van de Beek, Marleen, et al.
Publicado: (2019)

Cross-cohort generalizability of deep and conventional machine learning for MRI-based diagnosis and prediction of Alzheimer’s disease
por: Bron, Esther E., et al.
Publicado: (2021)

Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
por: Bos, Isabelle, et al.
Publicado: (2017)

Cognitive and functional progression of dementia in two longitudinal studies
por: Wang, Yuwei, et al.
Publicado: (2019)

A comparison of two approaches for modeling dementia progression in a changing patient context
por: Wubben, Nina, et al.
Publicado: (2022)

Vascular Cognitive Impairment in a Memory Clinic Population: Rationale and Design of the “Utrecht-Amsterdam Clinical Features and Prognosis in Vascular Cognitive Impairment” (TRACE-VCI) Study
por: Boomsma, Jooske Marije Funke, et al.
Publicado: (2017)

Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
por: Bos, Isabelle, et al.
Publicado: (2018)

A profile of The Clinical Course of Cognition and Comorbidity in Mild Cognitive Impairment and Dementia Study (The 4C study): two complementary longitudinal, clinical cohorts in the Netherlands
por: Liao, Weiqi, et al.
Publicado: (2016)

A Scoping Review of Communicating Neuropsychological Test Results to Patients and Family Members
por: Gruters, Angélique AA, et al.
Publicado: (2021)

Genome-wide association study of frontotemporal dementia identifies a C9ORF72 haplotype with a median of 12-G4C2 repeats that predisposes to pathological repeat expansions
por: Reus, Lianne M., et al.
Publicado: (2021)

Diagnostic and economic evaluation of new biomarkers for Alzheimer’s disease: the research protocol of a prospective cohort study
por: Handels, Ron LH, et al.
Publicado: (2012)

Diagnostic impact of [(18)F]flutemetamol PET in early-onset dementia
por: Zwan, Marissa D., et al.
Publicado: (2017)

Gray matter T1‐w/T2‐w ratios are higher in Alzheimer's disease
por: Pelkmans, Wiesje, et al.
Publicado: (2019)

Development of memory clinics in the Netherlands over the last 20 years
por: Gruters, Angélique A.A., et al.
Publicado: (2019)

Physical Performance in Memory Clinic Patients: The Potential Role of the White Matter Network
por: Verwer, Jurre H., et al.
Publicado: (2019)

Symptomatic Treatment of Vascular Cognitive Impairment (STREAM-VCI): Protocol for a Cross-Over Trial
por: Leijenaar, Jolien Fleur, et al.
Publicado: (2018)

Variability of CSF Alzheimer’s Disease Biomarkers: Implications for Clinical Practice
por: Vos, Stephanie J. B., et al.
Publicado: (2014)

Hippocampal sulcal cavities: prevalence, risk factors and association with cognitive performance. The SMART-Medea study and PREDICT-MR study
por: Blom, Kim, et al.
Publicado: (2018)

Grey matter network trajectories across the Alzheimer’s disease continuum and relation to cognition
por: Dicks, Ellen, et al.
Publicado: (2020)

Measuring Resilience and Resistance in Aging and Alzheimer Disease Using Residual Methods: A Systematic Review and Meta-analysis
por: Bocancea, Diana I., et al.
Publicado: (2021)

An Exploratory Study of the Development and Pilot Testing of an Interactive Visual Tool of Neuropsychological Test Results in Memory Clinics
por: Gruters, Angélique A.A., et al.
Publicado: (2021)

Small vessel disease lesion type and brain atrophy: The role of co‐occurring amyloid
por: Heinen, Rutger, et al.
Publicado: (2020)

Performance of five automated white matter hyperintensity segmentation methods in a multicenter dataset
por: Heinen, Rutger, et al.
Publicado: (2019)

Amsterdam Dementia Cohort: Performing Research to Optimize Care
por: van der Flier, Wiesje M., et al.
Publicado: (2018)

Grey matter network markers identify individuals with prodromal Alzheimer’s disease who will show rapid clinical decline
por: Pelkmans, Wiesje, et al.
Publicado: (2022)

A novel CCM2 variant in a family with non‐progressive cognitive complaints and cerebral microbleeds
por: Cohn‐Hokke, Petra E., et al.
Publicado: (2016)

Prodromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression
por: van de Beek, Marleen, et al.
Publicado: (2020)

Determinants of Cross-Sectional and Longitudinal Health-Related Quality of Life in Memory Clinic Patients Without Dementia
por: Banning, Leonie C. P., et al.
Publicado: (2019)

Disease progression in dementia with Lewy bodies: A longitudinal study on clinical symptoms, quality of life and functional impairment
por: van de Beek, Marleen, et al.
Publicado: (2022)

Joint assessment of white matter integrity, cortical and subcortical atrophy to distinguish AD from behavioral variant FTD: A two-center study
por: Möller, Christiane, et al.
Publicado: (2015)

Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease
por: Dicks, Ellen, et al.
Publicado: (2019)

Lower cerebral blood flow in subjects with Alzheimer's dementia, mild cognitive impairment, and subjective cognitive decline using two-dimensional phase-contrast magnetic resonance imaging
por: Leijenaar, Jolien F., et al.
Publicado: (2017)

The Dutch Parelsnoer Institute Cerebrovascular Disease Initiative: a retrospective study of the effects of integrating clinical care and research on costs and quality of care in patients with ischaemic stroke
por: Mensing, Liselore A, et al.
Publicado: (2019)

Resting state functional connectivity differences between behavioral variant frontotemporal dementia and Alzheimer's disease
por: Hafkemeijer, Anne, et al.
Publicado: (2015)

Improved Sensitivity to Cerebral White Matter Abnormalities in Alzheimer’s Disease with Spherical Deconvolution Based Tractography
por: Reijmer, Yael D., et al.
Publicado: (2012)

Widespread Disruption of Functional Brain Organization in Early-Onset Alzheimer’s Disease
por: Adriaanse, Sofie M., et al.
Publicado: (2014)

Microbleeds are associated with depressive symptoms in Alzheimer's disease
por: Leeuwis, Anna E., et al.
Publicado: (2017)

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment
por: ten Kate, Mara, et al.
Publicado: (2017)

Vascular Cognitive Impairment and cognitive decline; a longitudinal study comparing different types of vascular brain injury - The TRACE-VCI study
por: Boomsma, Jooske MF, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cp9d8ur8da3rhprkb2qccvcrpl